Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis

Background: Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape among non-small-cell lung cancer (NSCLC) patients. The efficacy of ICI therapy in older patients (≥65 years) is controversial and not fully clarified. We performed a systematic review and meta-analysis to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, You-Meng, Wang, Ying, Sun, Xin-Xing, Chen, Jing, Gong, Zhi-Ping, Meng, Hai-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538790/
https://www.ncbi.nlm.nih.gov/pubmed/33072584
http://dx.doi.org/10.3389/fonc.2020.558454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538790/
https://www.ncbi.nlm.nih.gov/pubmed/33072584
http://dx.doi.org/10.3389/fonc.2020.558454

Ejemplares similares